How will Zena compete with Opill, the first FDA-approved OTC birth control on the market?

Thank you for asking, Susannah. More than 90% of oral contraceptive pill users today are using the regular birth control pill, like Zena. Less than 10% are using progesterone only pills like Opill. Opill is the better choice if you are sensitive to estrogen and if you are breastfeeding. Zena will not be competing for those users because Zena is a combination pill that contains estrogen and progesterone. Ultimately, we want people to use the Pill that works best for them. We'll compete on maki...

Hi there, a) What is your most recent monthly burn rate? b) What is your most recent monthly cash on hand? c) Are you raising a parallel angel or VC round simultaneously? If yes, who is investing in this round?

Hi Teddy, thanks for these questions that are probably useful for others to know as well. a) Our most recent monthly burn rate is ~$400K. b) Our most recent cash on hand is ~$2.2M c) Yes we are simultaneously raising a venture/angel round with the same major terms. The lead for this round is a very sophisticated impact venture group called Soros Economic Development Fund, and also participating are Disney family office, Spielberg family office, Elizabeth Banks, Argosy Foundation, and some oth...

1) I'm trying to get a handle on your product history. Your pitch states that you acquired "rights to 3 of the most popular oral contraceptive formulas..." Does that mean Zena was previously available by prescription? (And if so, why not continue operating that revenue channel...

Hi Kevin, Thanks for the questions. 1) Yes Zena was available by prescription as Alesse. Cadence doesn't market prescription medications, we're focused on OTC access. 2) Yes Alesse is an FDA-approved product so safety and efficacy are established. The FDA's Rx-to-OTC switch process requires studies to prove that consumers can understand and follow the information without a physician's guidance. 3) No hurdles - our pregnancy test and UTI kit components are already FDA cleared for OTC sale. 4) ...

Hey I run an equity crowdfunding newsletter that goes out to 4,500 investors (https://crowdscale.beehiiv.com/). I'd love to interview you about your raise if you're interested! Reach out to hellocrowdscale@gmail.com to schedule something!

Hey Kevin, sounds good, thanks.

2023 Financials coming soon?

Hi Matthew, yes we're actually finishing a full audit process for 2023 which has delayed our financials a bit. We should be able to forward by the end of this coming week.

Cadence OTC

Condoms can be bought over-the-counter, but The Pill can't. We're changing that.

https://wefunder.com/cadenceotc

Total raised on Wefunder: 750188

Total investors: 352

Quick facts

Leading the Rx-to-OTC switch for The Pill to be sold without a prescription
Late stages of FDA approval to bring OTC birth control to market, with 3 years of market exclusivity
Already in market with 1st Morning After Pill in convenience stores - $3M revenue run rate (year 1)
Exclusive partnership with #1 distributor of healthcare products in 150K+ convenience stores
In 10+ retail chains including 7-Eleven, XtraMart, Jiffy Mart
Acquired the rights to three of the most popular oral contraceptive formulations from a major pharma
Team from Berkeley, Cambridge, Stanford, Yale & top brands like Flonase, OneTouch, & Herbal Essences
$36M in capital raised to date, backed by SEDF, RH Capital, Elizabeth Banks, Disney family

Investor memo sources

Jennifer Justice: https://uploads.wefunder.com/uploads/remote_files/820031-a6RhKaDqjRcRyJlxlk16rw58/Cadence_OTC_Investment_Memo.pdf (not paid for by company)

Team profiles

Featured investor profiles

Cadence OTC

Condoms can be bought over-the-counter, but The Pill can't. We're changing that.

cadenceotc.com

Oakland, CA

Female Founder Healthcare Ecommerce Consumer Goods Retail

Ask a Question

Cadence OTC

Quick facts

Investor memo sources

Team profiles

Featured investor profiles

$1,750,188

Ask